It has been a remarkable start to the year. Two months in and who would have predicted that the Dow Jones Industrial Average would have soared past 21,000 and the Nasdaq Biotech Index return a year-to-date (YTD) gain of more than 12 percent? It has been an unexpected, but welcome, turn of events. Read More
